Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterGlobeNewsWire • Wednesday
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™GlobeNewsWire • 04/03/24
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 03/28/24
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024GlobeNewsWire • 03/15/24
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in StrokeGlobeNewsWire • 03/12/24
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH ConferenceGlobeNewsWire • 03/07/24
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and ControllerGlobeNewsWire • 03/04/24
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke PatientsGlobeNewsWire • 02/06/24
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MSGlobeNewsWire • 02/05/24
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation HospitalGlobeNewsWire • 01/11/24
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should KnowZacks Investment Research • 12/07/23
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to WorkGlobeNewsWire • 11/06/23
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024GlobeNewsWire • 11/02/23
Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® DevicesGlobeNewsWire • 10/12/23
Helius Medical Technologies to Participate at Two Upcoming Healthcare ConferencesGlobeNewsWire • 10/02/23
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and MouthpieceGlobeNewsWire • 09/28/23
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy ConferenceGlobeNewsWire • 09/21/23
University of Montreal's School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke RecoveryGlobeNewsWire • 09/20/23
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation ConferenceGlobeNewsWire • 09/13/23
How Much Upside is Left in Helius Medical Technologies, Inc. (HSDT)? Wall Street Analysts Think 1183.3%Zacks Investment Research • 09/06/23